Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Amol Palkar"'
Autor:
Amit Harshana, Raman Mahajan, Reshu Agarwal, Shrikala Acharya, Amol Palkar, Ramesh Reddy Allam, Vijay Kumar Karanjkar, Dhirubhai Rathod, Prashant Deshpande, Shashikant Todmal, Sagar Koli, Sachin Dhande, Jayesh Dale, Vijay V Yeldandi, Sunita Upadhyaya, Melissa Nyendak
Publikováno v:
BMJ Open, Vol 13, Iss 6 (2023)
Objectives To describe the implementation of screening for cryptococcal antigenaemia by point-of-care (POC) serum cryptococcal antigen (CrAg) lateral flow assay, measure the prevalence and factors associated with serum cryptococcal antigenaemia in th
Externí odkaz:
https://doaj.org/article/ead81ea3ef2e45619b31eecd8ba0acd2
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 10, Iss 2, Pp 758-764 (2021)
Background: Knowledge of factors that affect survival in People living with HIV/AIDS (PLHAs) on anti-retroviral therapy (ART) will help us develop and implement interventions to improve the clinical outcomes and survival in these individuals. The aim
Externí odkaz:
https://doaj.org/article/87ba04b9b8ad4d8c8555f5ce4812ecac
Publikováno v:
Indian Journal of Dermatology, Vol 66, Iss 4, Pp 378-385 (2021)
Background: Poor adherence to antiretroviral therapy (ART) is associated with poor virologic control and drug resistance in people living with HIV/AIDS. Some barriers to ART adherence are cost, lack of information, stigma, or dissatisfaction with hea
Externí odkaz:
https://doaj.org/article/0ccfb127a6464c5381f3dc9289290729
Autor:
Shrikala Acharya, Prashant Deshpande, Edwin Sam Asirvatham, Amol Palkar, Charishma Jones Sarman, Chinmay Laxmeshwar, Maninder Singh Setia, Dhirubhai Rathod, Sagar Koli, Jayesh Dale, Vijay Yeldandi, Ramesh Allam, Reshu Agarwal, Sanjeev Verma, Sunita Upadhyaya, Melissa Nyendak
Publikováno v:
PLoS ONE, Vol 17, Iss 9, p e0273970 (2022)
BackgroundPeople with Advanced HIV Disease (AHD) are at higher risk of TB coinfection and mortality. However, there are challenges in TB diagnosis with the currently recommended diagnostic tools. WHO recommends lateral flow urine lipoarabinomannan (L
Externí odkaz:
https://doaj.org/article/0951857f9df04651954cc27db4d56157
Publikováno v:
BMJ Open, Vol 11, Iss 9 (2021)
Objectives To understand the survival in a cohort of children living with HIV/AIDS (CLHAs) and to study the factors associated with survival in CLHAs in government antiretroviral therapy (ART) centres in Mumbai, India.Design This is a retrospective c
Externí odkaz:
https://doaj.org/article/be16797742a040d89eed4c9e4e95a088
Publikováno v:
Journal of Family Medicine and Primary Care
Journal of Family Medicine and Primary Care, Vol 10, Iss 2, Pp 758-764 (2021)
Journal of Family Medicine and Primary Care, Vol 10, Iss 2, Pp 758-764 (2021)
Background: Knowledge of factors that affect survival in People living with HIV/AIDS (PLHAs) on anti-retroviral therapy (ART) will help us develop and implement interventions to improve the clinical outcomes and survival in these individuals. The aim
Publikováno v:
BMJ Open, Vol 11, Iss 9 (2021)
ObjectivesTo understand the survival in a cohort of children living with HIV/AIDS (CLHAs) and to study the factors associated with survival in CLHAs in government antiretroviral therapy (ART) centres in Mumbai, India.DesignThis is a retrospective coh
Autor:
M Vishnu Vardhana Rao, Arumugam Elangovan, Shashi Kant, Sheela Godbole, Saritha Nair, Shobini Rajan, Arvind Pandey, Deepika Joshi, Pradeep Kumar, Amol Palkar, P V M Lakshmi, Amitabh Das, S. K. Singh, Anil Kumar, Savina Ammassari, Poonam Bakshi, Sabyasachi Chakraborty, D. K. Shukla, S. Srikanth Reddy, S. Venkatesh, Damodar Sahu, D C S Reddy, Jitenkumar Singh, T Gambhir, Nalini Chandra, Sanjay K Rai, Malay Kumar Saha
Publikováno v:
The Indian Journal of Medical Research
Indian Journal of Medical Research, Vol 151, Iss 6, Pp 562-570 (2020)
Indian Journal of Medical Research, Vol 151, Iss 6, Pp 562-570 (2020)
Background & objectives: The National AIDS Control Organisation (NACO) and the ICMR-National Institute of Medical Statistics, the nodal agency for conducting HIV estimations in India, have been generating HIV estimates regularly since 2003. The objec